Prediction of Immunotherapeutic Effect of Advanced Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To detect the difference of PD-L1 and miRNA expression profiles of exosomes in NSCLC patients
before and after immunotherapy, and to explore the potential of plasma exosomes PD-L1 and
miRNAs as biomarkers to predict the therapeutic effect of NSCLC on anti-PD-1 / PD-L1.